1-8 of 8
Antonio E. Pontiroli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comment on Lent et al. All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes. Diabetes Care 2017;40:1379–1385

Antonio E. Pontiroli, Ahmed S. Zakaria
Journal: Diabetes Care
Diabetes Care 2018;41(2):e19
https://doi.org/10.2337/dc17-1895
Published: 12 January 2018
View article titled, Comment on Lent et al. All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes. Diabetes Care 2017;40:1379–1385
Open the PDF for Comment on Lent et al. All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes. Diabetes Care 2017;40:1379–1385 in another window
Journal Articles

Cholesterol Metabolism After Bariatric Surgery in Grade 3 Obesity: Differences between malabsorptive and restrictive procedures

Alberto Benetti, MD, Marina Del Puppo, PHD, Andrea Crosignani, MD, Annamaria Veronelli, MD, Enzo Masci, MD, Francesca Frigè, BSC, Giancarlo Micheletto, MD, Valerio Panizzo, MD, Antonio E. Pontiroli, MD
Journal: Diabetes Care
Diabetes Care 2013;36(6):1443–1447
https://doi.org/10.2337/dc12-1737
Published: 15 May 2013
View article titled, Cholesterol Metabolism After Bariatric Surgery in Grade 3 Obesity: <subtitle>Differences between malabsorptive and restrictive procedures</subtitle>
Open the PDF for Cholesterol Metabolism After Bariatric Surgery in Grade 3 Obesity: <subtitle>Differences between malabsorptive and restrictive procedures</subtitle> in another window
Journal Articles

Sympathetic Overactivity, Endothelial Dysfunction, Inflammation, and Metabolic Abnormalities Cluster in Grade III (World Health Organization) Obesity: Reversal through sustained weight loss obtained with laparoscopic adjustable gastric banding

Antonio E. Pontiroli, MD, Pierluigi Pizzocri, MD, Rita Paroni, PHD, Franco Folli, MD
Journal: Diabetes Care
Diabetes Care 2006;29(12):2735–2738
https://doi.org/10.2337/dc06-1417
Published: 01 December 2006
View article titled, Sympathetic Overactivity, Endothelial Dysfunction, Inflammation, and Metabolic Abnormalities Cluster in Grade III (World Health Organization) Obesity: <subtitle>Reversal through sustained weight loss obtained with laparoscopic adjustable gastric banding</subtitle>
Open the PDF for Sympathetic Overactivity, Endothelial Dysfunction, Inflammation, and Metabolic Abnormalities Cluster in Grade III (World Health Organization) Obesity: <subtitle>Reversal through sustained weight loss obtained with laparoscopic adjustable gastric banding</subtitle> in another window
Journal Articles

Laparoscopic Gastric Banding Prevents Type 2 Diabetes and Arterial Hypertension and Induces Their Remission in Morbid Obesity: A 4-year case-controlled study

Antonio E. Pontiroli, MD, Franco Folli, MD, PHD, Michele Paganelli, MD, Giancarlo Micheletto, MD, Pierluigi Pizzocri, MD, Paola Vedani, MD, Francesca Luisi, PHD, Lucia Perego, PHD, Alberto Morabito, PHD, Santo Bressani Doldi, MD
Journal: Diabetes Care
Diabetes Care 2005;28(11):2703–2709
https://doi.org/10.2337/diacare.28.11.2703
Published: 01 November 2005
View article titled, Laparoscopic Gastric Banding Prevents Type 2 Diabetes and Arterial Hypertension and Induces Their Remission in Morbid Obesity: <subtitle>A 4-year case-controlled study</subtitle>
Open the PDF for Laparoscopic Gastric Banding Prevents Type 2 Diabetes and Arterial Hypertension and Induces Their Remission in Morbid Obesity: <subtitle>A 4-year case-controlled study</subtitle> in another window
Journal Articles

C-174G Polymorphism in the Promoter of the Interleukin-6 Gene Is Associated With Insulin Resistance

Marina Cardellini, MD, Lucia Perego, PHD, Monica D’Adamo, MD, Maria Adelaide Marini, MD, Cristina Procopio, Marta Letizia Hribal, PHD, Francesco Andreozzi, MD, Simona Frontoni, MD, Maurizio Giacomelli, MD, Michele Paganelli, MD, Antonio E. Pontiroli, MD, Renato Lauro, MD, Franco Folli, MD, Giorgio Sesti, MD
Journal: Diabetes Care
Diabetes Care 2005;28(8):2007–2012
https://doi.org/10.2337/diacare.28.8.2007
Published: 01 August 2005
View article titled, C-174G Polymorphism in the Promoter of the Interleukin-6 Gene Is Associated With Insulin Resistance
Open the PDF for C-174G Polymorphism in the Promoter of the Interleukin-6 Gene Is Associated With Insulin Resistance in another window
Journal Articles

White Blood Cells in Obesity and Diabetes: Effects of weight loss and normalization of glucose metabolism

Anna Veronelli, MD, Marco Laneri, MD, Roberto Ranieri, MD, Diana Koprivec, MD, Debora Vardaro, BSC, Michele Paganelli, MD, Franco Folli, MD, Antonio E. Pontiroli, MD
Journal: Diabetes Care
Diabetes Care 2004;27(10):2501–2502
https://doi.org/10.2337/diacare.27.10.2501
Published: 01 October 2004
View article titled, White Blood Cells in Obesity and Diabetes: <subtitle>Effects of weight loss and normalization of glucose metabolism</subtitle>
Open the PDF for White Blood Cells in Obesity and Diabetes: <subtitle>Effects of weight loss and normalization of glucose metabolism</subtitle> in another window
Journal Articles

The Possible Role of Insulin Release in Cardiovascular Morbidity and Mortality in NIDDM Patients

Antonio E Pontiroli, MD, Manuela Pacchioni, MD, R Camisasca, MD, Guido Pozza, MD
Journal: Diabetes Care
Diabetes Care 1995;18(11):1506
https://doi.org/10.2337/diacare.18.11.1506a
Published: 01 November 1995
View article titled, The Possible Role of Insulin Release in Cardiovascular Morbidity and Mortality in NIDDM Patients
Open the PDF for The Possible Role of Insulin Release in Cardiovascular Morbidity and Mortality in NIDDM Patients in another window
Journal Articles

Intranasal Glucagon as Remedy for Hypoglycemia: Studies in Healthy Subjects and Type I Diabetic Patients

Antonio E Pontiroli, MD, Anna Calderara, MD, Elena Pajetta, MD, Miriam Alberetto, MD, Guido Pozza, MD
Journal: Diabetes Care
Diabetes Care 1989;12(9):604–609
https://doi.org/10.2337/diacare.12.9.604
Published: 01 October 1989
View article titled, Intranasal Glucagon as Remedy for Hypoglycemia: Studies in Healthy Subjects and Type I Diabetic Patients
Open the PDF for Intranasal Glucagon as Remedy for Hypoglycemia: Studies in Healthy Subjects and Type I Diabetic Patients in another window